l-carnitine drug classification Role of in Cardiovascular Health: Literature Review L-Carnitine ((R)-Carnitine) | Co-factor for

According to the literature from the past 30 years, the main central nervous system manifestations of MMA are as follows: prominence of the ventricles 21 , myelination abnormalities 22 , cortical atrophy and sulcal widening 23,24 , periventricular white matter abnormalities 25 , internal capsule changes 26 , basal ganglia changes 27 , cerebellar atrophy, subcortical white matter changes, and thinning of the corpus callosum 28,29,30

however, it does not have the vasodilatory, hypolipidemic, and gastrointestinal upset

Jan 2014;53(1):19-31

List of Key and Emerging Players in L-Carnitine Market Northeast Pharmaceutical Group Co.LTD